Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AKR Corporindo Tbk (AKRA) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance

AKR Corporindo TbkTrade
Mizuho Leasing Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

AKR Corporindo Tbk vs Mizuho Leasing Indonesia Tbk. — how do they compare? AKR Corporindo Tbk trades at Rp1,400 (market cap 28T, 6.58M 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp75 (market cap 426.55B, 34.9K 24h volume). The key difference: AKR Corporindo Tbk is far larger — about 65.6× Mizuho Leasing Indonesia Tbk.'s market cap, and AKR Corporindo Tbk is more actively traded (6.58M versus 34.9K). Which is the better fit depends on your goals.

AKRAVRNA
Market Cap
28T426.55B
Volume
6.58M34.9K
Lot
65.84K349
Turnover
9.25B2.6M
Average Price
1,405.1474.58
Value
9.25B2.6M
Indicative Equilibrium Price
1,400
Indicative Equilibrium Volume
1.94K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AKRA
View details
VRNA
View details

About AKR Corporindo Tbk

PT AKR Corporindo Tbk was established in Surabaya on November 28, 1977 based on the Notarial Deed No. 46 of Sastra Kosasih, S.H., which was amended by Notarial Deed No. 26 of the same notary dated April 12, 1978 . In 2004, the Company changed its name from PT Aneka Kimia Raya Tbk to PT AKR Corporindo Tbk. PT Aneka Kimia Raya is the largest chemical distributor in Indonesia. The Company is dominantly positioned within the industry, distributing more than 40 chemical products. The Company is foreign investment.

Read more on AKRA

About Mizuho Leasing Indonesia Tbk.

PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.

Read more on VRNA